Search research articles
Contact Us
Filters
Showing results (231-240 of 267) with videos related to
Page
of 27
Sort By:
International Journal of Radiation Oncology, Biology, Physics
|
November 7, 2006
Targeted intraoperative radiotherapy (TARGIT) yields very low recurrence rates when given as a boost
Jayant S Vaidya, Michael Baum, Jeffrey S Tobias, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 1, 2021
Radiation and Androgen Deprivation Therapy With or Without Docetaxel in the Management of Nonmetastatic Unfavorable-Risk Prostate Cancer: A Prospective Randomized Trial
Anthony V D'Amico, Wanling Xie, Elizabeth McMahon, et al.
Neurology
|
August 30, 2022
Racial Disparities in Stroke Recurrence: A Population-Based Study
David Joseph Robinson, Robert Stanton, Heidi Sucharew, et al.
Resuscitation
|
March 25, 2008
Emergency treatment of anaphylactic reactions--guidelines for healthcare providers
Jasmeet Soar, Richard Pumphrey, Andrew Cant, et al.
Mabs
|
May 10, 2019
Retrospective analysis of model-based predictivity of human pharmacokinetics for anti-IL-36R monoclonal antibody MAB92 using a rat anti-mouse IL-36R monoclonal antibody and RNA expression data (FANTOM5)
Jennifer Ahlberg, Craig Giragossian, Hua Li, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
October 28, 2008
Is there more than one proctitis syndrome? A revisitation using data from the TROG 96.01 trial
Anne Capp, Mario Inostroza-Ponta, Dana Bill, et al.
The Journal of Clinical Endocrinology and Metabolism
|
June 17, 2011
Clinical characteristics and diagnostic criteria of maturity-onset diabetes of the young (MODY) due to molecular anomalies of the HNF1A gene
Christine Bellanné-Chantelot, David Joseph Lévy, Claire Carette, et al.
Annals of the Rheumatic Diseases
|
March 24, 2019
Effects of BI 655064, an antagonistic anti-CD40 antibody, on clinical and biomarker variables in patients with active rheumatoid arthritis: a randomised, double-blind, placebo-controlled, phase IIa study
Sudha Visvanathan, Stefan Daniluk, Rafał Ptaszyński, et al.
Bioorganic & Medicinal Chemistry Letters
|
January 1, 2019
Identification of novel azaindazole CCR1 antagonist clinical candidates
Christian Harcken, Daniel Kuzmich, Brain Cook, et al.
Bioorganic & Medicinal Chemistry Letters
|
November 21, 2018
Discovery and optimization of pyrazole amides as antagonists of CCR1
Christian Harcken, Christopher Sarko, Can Mao, et al.
Page
of 27
Search research articles
Search
Showing results (231-240 of 267) with videos related to
Sort By:
Page
of 27
International Journal of Radiation Oncology, Biology, Physics
|
November 7, 2006
Targeted intraoperative radiotherapy (TARGIT) yields very low recurrence rates when given as a boost
Jayant S Vaidya, Michael Baum, Jeffrey S Tobias, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 1, 2021
Radiation and Androgen Deprivation Therapy With or Without Docetaxel in the Management of Nonmetastatic Unfavorable-Risk Prostate Cancer: A Prospective Randomized Trial
Anthony V D'Amico, Wanling Xie, Elizabeth McMahon, et al.
Neurology
|
August 30, 2022
Racial Disparities in Stroke Recurrence: A Population-Based Study
David Joseph Robinson, Robert Stanton, Heidi Sucharew, et al.
Resuscitation
|
March 25, 2008
Emergency treatment of anaphylactic reactions--guidelines for healthcare providers
Jasmeet Soar, Richard Pumphrey, Andrew Cant, et al.
Mabs
|
May 10, 2019
Retrospective analysis of model-based predictivity of human pharmacokinetics for anti-IL-36R monoclonal antibody MAB92 using a rat anti-mouse IL-36R monoclonal antibody and RNA expression data (FANTOM5)
Jennifer Ahlberg, Craig Giragossian, Hua Li, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
October 28, 2008
Is there more than one proctitis syndrome? A revisitation using data from the TROG 96.01 trial
Anne Capp, Mario Inostroza-Ponta, Dana Bill, et al.
The Journal of Clinical Endocrinology and Metabolism
|
June 17, 2011
Clinical characteristics and diagnostic criteria of maturity-onset diabetes of the young (MODY) due to molecular anomalies of the HNF1A gene
Christine Bellanné-Chantelot, David Joseph Lévy, Claire Carette, et al.
Annals of the Rheumatic Diseases
|
March 24, 2019
Effects of BI 655064, an antagonistic anti-CD40 antibody, on clinical and biomarker variables in patients with active rheumatoid arthritis: a randomised, double-blind, placebo-controlled, phase IIa study
Sudha Visvanathan, Stefan Daniluk, Rafał Ptaszyński, et al.
Bioorganic & Medicinal Chemistry Letters
|
January 1, 2019
Identification of novel azaindazole CCR1 antagonist clinical candidates
Christian Harcken, Daniel Kuzmich, Brain Cook, et al.
Bioorganic & Medicinal Chemistry Letters
|
November 21, 2018
Discovery and optimization of pyrazole amides as antagonists of CCR1
Christian Harcken, Christopher Sarko, Can Mao, et al.
Page
of 27